GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Equity-to-Asset

Albert Labs International (XCNQ:ABRT) Equity-to-Asset : -6.82 (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Albert Labs International's Total Stockholders Equity for the quarter that ended in Sep. 2023 was C$-0.44 Mil. Albert Labs International's Total Assets for the quarter that ended in Sep. 2023 was C$0.07 Mil.

The historical rank and industry rank for Albert Labs International's Equity-to-Asset or its related term are showing as below:

XCNQ:ABRT' s Equity-to-Asset Range Over the Past 10 Years
Min: -6.82   Med: -1.82   Max: 0.74
Current: -6.82

During the past 2 years, the highest Equity to Asset Ratio of Albert Labs International was 0.74. The lowest was -6.82. And the median was -1.82.

XCNQ:ABRT's Equity-to-Asset is ranked worse than
96.85% of 1558 companies
in the Biotechnology industry
Industry Median: 0.67 vs XCNQ:ABRT: -6.82

Albert Labs International Equity-to-Asset Historical Data

The historical data trend for Albert Labs International's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Equity-to-Asset Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Equity-to-Asset
-1.41 -2.23

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 -2.23 -2.60 -6.00 -6.82

Competitive Comparison of Albert Labs International's Equity-to-Asset

For the Biotechnology subindustry, Albert Labs International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Albert Labs International's Equity-to-Asset falls into.



Albert Labs International Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Albert Labs International's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=-0.365/0.164
=

Albert Labs International's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=-0.443/0.065
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International  (XCNQ:ABRT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Albert Labs International Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines